[Clinical-pharmacological studies on a new orally active adenosine derivative].
D000241:Adenosine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004361:Drug Tolerance; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects; D000637:Transaminases / Q000097:blood; D014665:Vasodilator Agents / Q000494:pharmacology*
D001593:Benzyl Compounds; D005230:Fatty Acids, Nonesterified; D014665:Vasodilator Agents; D000637:Transaminases; D000241:Adenosine
Klinisch-pharmakologische Untersuchungen mit einem neuen peroral wirksamen Adenosinderivat.